Seaport Therapeutics shares jumped 17% in their trading debut after the company raised nearly $255 million in an upsized IPO. The strong first-day performance points to solid investor demand for the healthcare biotech name and a favorable pricing outcome for the offering.
Seaport Therapeutics shares jumped 17% in their trading debut after the company raised nearly $255 million in an upsized IPO. The strong first-day performance points to solid investor demand for the healthcare biotech name and a favorable pricing outcome for the offering.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
